Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India
· Delayed Price · Currency is INR 1,727.50
+44.90 (2.67%)
Jul 15, 2025, 3:30 PM IST
NSE:SUNPHARMA Revenue
In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B INR with 8.42% growth. Sun Pharmaceutical Industries had revenue of 129.59B in the quarter ending March 31, 2025, with 8.14% growth.
Revenue
525.78B
Revenue Growth
+8.42%
P/S Ratio
7.88
Revenue / Employee
12.23M
Employees
43,000
Market Cap
4,144.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
| Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
| Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
| Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
| Mar 31, 2021 | 334.98B | 6.61B | 2.01% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Mankind Pharma | 122.07B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Glenmark Pharmaceuticals | 134.35B |
| Fortis Healthcare | 77.83B |
Sun Pharmaceutical Industries News
- 10 hours ago - Nifty top gainers today, July 15: Hero MotoCorp, Bajaj Auto, Sun Pharma, Shriram Finance, Apollo Hospitals and more - Business Upturn
- 1 day ago - Sun Pharma Announces Launch of LEQSELVI™ (deuruxolitinib) in the United States for the Treatment of Severe Alopecia Areata - Benzinga
- 1 day ago - Sun Pharma announces settlement with Incyte Corporation over LEQSELVI litigation - Business Upturn
- 1 day ago - Morgan Stanley turns selective on Indian pharma, initiates call on Sun Pharma, Lupin, DRL, CIPLA shares - Business Upturn
- 7 days ago - Nomura says IPM growth accelerated to 8% in June; IPCA, Sun Pharma lead gains - Business Upturn
- 8 days ago - Drugs Control Administration (DCA) seizes fake Levipil 500 tablets in major Hyderabad raid - The Times of India
- 15 days ago - Torrent Pharma becomes India’s 5th largest drugmaker - The Times of India
- 4 weeks ago - Nifty 50 top losers today, June 17: Adani Enterprises, Dr. Reddy’s, Tata Motors, Sun Pharma lead declines - Business Upturn